Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
CNY | Fiscal Year Ending | | Latest |
(in millions) | | | | Dec-18 | Dec-19 | Dec-20 | Dec-21 | Dec-22 | Dec-23 | Dec-24 | | Dec-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 0 | 0 | 0 | 4,689 | 5,114 | 3,032 | 3,814 | 4,769 | 4,469 | 5,272 | | 5,272 |
% Growth | NA | NA | NA | NA | 9.1% | -40.7% | 25.8% | 25.0% | -6.3% | 18.0% | | |
| | | | | | | | | | | | |
Cost of Revenue | 0 | 0 | 0 | (4,347) | (4,761) | (2,515) | (3,039) | (3,779) | (3,714) | (4,453) | | (4,453) |
Gross Profit | 0 | 0 | 0 | 342 | 353 | 518 | 775 | 990 | 755 | 819 | | 819 |
% Revenue | NA | NA | NA | 7.3% | 6.9% | 17.1% | 20.3% | 20.8% | 16.9% | 15.5% | | 15.5% |
| | | | | | | | | | | | |
Research and Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (7) | (9) | | (9) |
Selling and Marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
General and Admin | 0 | 0 | 0 | (111) | (115) | (114) | (135) | (150) | (158) | (175) | | (175) |
Other Inc / (Exp) | 0 | 0 | 0 | (5) | 41 | 14 | 28 | 88 | 56 | 92 | | 92 |
Total Operating Exp | 0 | 0 | 0 | (115) | (74) | (100) | (107) | (62) | (109) | (91) | | (91) |
| | | | | | | | | | | | |
Operating Income | 0 | 0 | 0 | 227 | 279 | 418 | 668 | 927 | 646 | 727 | | 727 |
% Revenue | NA | NA | NA | 4.8% | 5.5% | 13.8% | 17.5% | 19.4% | 14.5% | 13.8% | | 13.8% |
| | | | | | | | | | | | |
Interest Expense | 0 | 0 | 0 | (30) | (23) | (5) | 21 | (26) | 16 | 2 | | 2 |
Pre-tax Income | 0 | 0 | 0 | 197 | 256 | 413 | 689 | 901 | 663 | 729 | | 729 |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | 0 | 0 | 0 | (50) | (68) | (108) | (168) | (231) | (162) | (174) | | (174) |
Net Income to Company | 0 | 0 | 0 | 147 | 188 | 304 | 521 | 670 | 501 | 555 | | 555 |
% Margin | NA | NA | NA | 3.1% | 3.7% | 10.0% | 13.7% | 14.1% | 11.2% | 10.5% | | 10.5% |
| | | | | | | | | | | | |
Minority Interest in Earnings | 0 | 0 | 0 | (5) | (4) | (0) | (0) | (0) | 3 | (2) | | (2) |
Net Income to Stockholders | 0 | 0 | 0 | 142 | 185 | 304 | 521 | 670 | 504 | 554 | | 554 |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | 0 | 0 | 0 | 142 | 185 | 304 | 521 | 670 | 504 | 554 | | 554 |
% Margin | NA | NA | NA | 3.0% | 3.6% | 10.0% | 13.6% | 14.0% | 11.3% | 10.5% | | 10.5% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.34 | 0.45 | 0.57 | 0.39 | 0.42 | | 0.42 |
Diluted EPS (Continuing Ops) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.34 | 0.45 | 0.57 | 0.39 | 0.42 | | 0.42 |
| | | | | | | | | | | | |
WA Basic Shares Out. | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 900.00 | 1,156.89 | 1,175.25 | 1,292.40 | 1,318.43 | | 1,318.43 |
WA Diluted Shares Out. | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 900.00 | 1,156.89 | 1,175.25 | 1,292.40 | 1,318.43 | | 1,318.43 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | 0 | 0 | 0 | 197 | 256 | 413 | 689 | 901 | 663 | 729 | | 729 |
Addback: Net Interest Expense | 0 | 0 | 0 | 30 | 23 | 5 | (21) | 26 | (16) | (2) | | (2) |
Addback: Other Non Operating Expenses, Total | 0 | 0 | 0 | 15 | (0) | 12 | 20 | (60) | 14 | (41) | | (41) |
Addback: Depreciation & Amortization | 0 | 0 | 0 | 159 | 155 | 153 | 140 | 201 | 240 | 356 | | 356 |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Assets | 0 | 0 | 0 | (3) | (0) | (0) | (2) | (0) | (2) | (0) | | (0) |
Addback: Asset Writedown | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9 | 0 | (0) | | (0) |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 20 | 0 | 0 | 17 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | 0 | 0 | 0 | (18) | (23) | (9) | (69) | (57) | (53) | 0 | | 0 |
Adjusted EBITDA | 0 | 0 | 0 | 401 | 411 | 573 | 774 | 1,020 | 844 | 1,041 | | 1,041 |
% Margin | NA | NA | NA | 8.6% | 8.0% | 18.9% | 20.3% | 21.4% | 18.9% | 19.8% | | 19.8% |
| | | | | | | | | | | | |
Adjusted EBIT | 0 | 0 | 0 | 242 | 256 | 420 | 634 | 819 | 604 | 686 | | 686 |
% Margin | NA | NA | NA | 5.2% | 5.0% | 13.9% | 16.6% | 17.2% | 13.5% | 13.0% | | 13.0% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | 0 | 0 | 0 | 147 | 188 | 304 | 521 | 670 | 501 | 555 | | 555 |
Addback: Unusual Items | 0 | 0 | 0 | 0 | (23) | (9) | (54) | (48) | (56) | (0) | | (0) |
Less: Tax Benefit of Unusual Items (26%) | 0 | 0 | 0 | (0) | 6 | 2 | 14 | 13 | 15 | 0 | | 0 |
Adjusted Net Income | 0 | 0 | 0 | 147 | 172 | 298 | 481 | 634 | 459 | 555 | | 555 |
% Margin | NA | NA | NA | 3.1% | 3.4% | 9.8% | 12.6% | 13.3% | 10.3% | 10.5% | | 10.5% |